Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Denton

Showing results (221-230 of 484) with videos related to

Pageof 49
Sort By:
Journal of Cell Science|October 2, 2008
Loss of protein kinase Cepsilon results in impaired cutaneous wound closure and myofibroblast functionAndrew Leask, Xu Shi-Wen, Korsa Khan, et al.
Rheumatology (Oxford, England)|September 15, 2012
Focal adhesion kinase and reactive oxygen species contribute to the persistent fibrotic phenotype of lesional scleroderma fibroblastsXu Shi-wen, Katherine Thompson, Korsa Khan, et al.
The Journal of Clinical Investigation|September 20, 2008
GSK-3beta in mouse fibroblasts controls wound healing and fibrosis through an endothelin-1-dependent mechanismMohit Kapoor, Shangxi Liu, Xu Shi-wen, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Patient perception of disease burden in diffuse cutaneous systemic sclerosisDinesh Khanna, Yannick Allanore, Christopher P Denton, et al.
The Journal of Investigative Dermatology|May 7, 2010
Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosisNima Aden, Anna Nuttall, Xu Shiwen, et al.
Rheumatology (Oxford, England)|January 3, 2025
Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysisNina R Goldman, Svetlana I Nihtyanova, Claire F Beesley, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 27, 2021
Systemic Sclerosis-Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration-Approved Therapies in Clinical PracticeDinesh Khanna, Alain Lescoat, David Roofeh, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2014
Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosisRobyn T Domsic, Svetlana I Nihtyanova, Stephen R Wisniewski, et al.
Annals of the Rheumatic Diseases|June 2, 2018
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosisChristopher P Denton, Voon H Ong, Shiwen Xu, et al.
Cells|July 14, 2023
Single-Cell Analysis of ADSC Interactions with Fibroblasts and Endothelial Cells in Scleroderma SkinMarvin L Frommer, Benjamin J Langridge, Laura Awad, et al.
Pageof 49

Showing results (221-230 of 484) with videos related to

Sort By:
Pageof 49
Journal of Cell Science|October 2, 2008
Loss of protein kinase Cepsilon results in impaired cutaneous wound closure and myofibroblast functionAndrew Leask, Xu Shi-Wen, Korsa Khan, et al.
Rheumatology (Oxford, England)|September 15, 2012
Focal adhesion kinase and reactive oxygen species contribute to the persistent fibrotic phenotype of lesional scleroderma fibroblastsXu Shi-wen, Katherine Thompson, Korsa Khan, et al.
The Journal of Clinical Investigation|September 20, 2008
GSK-3beta in mouse fibroblasts controls wound healing and fibrosis through an endothelin-1-dependent mechanismMohit Kapoor, Shangxi Liu, Xu Shi-wen, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Patient perception of disease burden in diffuse cutaneous systemic sclerosisDinesh Khanna, Yannick Allanore, Christopher P Denton, et al.
The Journal of Investigative Dermatology|May 7, 2010
Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosisNima Aden, Anna Nuttall, Xu Shiwen, et al.
Rheumatology (Oxford, England)|January 3, 2025
Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysisNina R Goldman, Svetlana I Nihtyanova, Claire F Beesley, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 27, 2021
Systemic Sclerosis-Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration-Approved Therapies in Clinical PracticeDinesh Khanna, Alain Lescoat, David Roofeh, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2014
Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosisRobyn T Domsic, Svetlana I Nihtyanova, Stephen R Wisniewski, et al.
Annals of the Rheumatic Diseases|June 2, 2018
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosisChristopher P Denton, Voon H Ong, Shiwen Xu, et al.
Cells|July 14, 2023
Single-Cell Analysis of ADSC Interactions with Fibroblasts and Endothelial Cells in Scleroderma SkinMarvin L Frommer, Benjamin J Langridge, Laura Awad, et al.
Pageof 49